GENERATION INVESTMENT MANAGEMENT LLP has added 682,107 shares of $WST to their portfolio, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 03-31-2026 report period. You can see the fund's full portfolio on Quiver Quantitative, and also track the largest institutional owners of $WST.
WEST PHARMACEUTICAL SVSC Hedge Fund Activity
We have seen 346 institutional investors add shares of WEST PHARMACEUTICAL SVSC stock to their portfolio, and 401 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DURABLE CAPITAL PARTNERS LP removed 1,172,583 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $322,624,486
- FRANKLIN RESOURCES INC removed 876,596 shares (-98.7%) from their portfolio in Q1 2026, for an estimated $219,710,021
- LONGVIEW PARTNERS (GUERNSEY) LTD added 778,887 shares (+221.2%) to their portfolio in Q4 2025, for an estimated $214,302,969
- VAN ECK ASSOCIATES CORP removed 708,792 shares (-49.7%) from their portfolio in Q4 2025, for an estimated $195,017,030
- GENERATION INVESTMENT MANAGEMENT LLP added 682,107 shares (+43.7%) to their portfolio in Q1 2026, for an estimated $170,963,298
- CAPITAL RESEARCH GLOBAL INVESTORS added 604,011 shares (+inf%) to their portfolio in Q1 2026, for an estimated $151,389,317
- BROWN ADVISORY INC removed 554,476 shares (-22.2%) from their portfolio in Q4 2025, for an estimated $152,558,526
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
WEST PHARMACEUTICAL SVSC Insider Trading Activity
WEST PHARMACEUTICAL SVSC insiders have traded $WST stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $WST stock by insiders over the last 6 months:
- ANNETTE F FAVORITE (Sr. VP & Chief HR Officer) sold 2,817 shares for an estimated $859,753
- CHAD WINTERS (VP, Chief Accounting Officer) sold 896 shares for an estimated $269,399
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
WEST PHARMACEUTICAL SVSC Price Targets
Multiple analysts have issued price targets for $WST recently. We have seen 3 analysts offer price targets for $WST in the last 6 months, with a median target of $310.0.
Here are some recent targets:
- Luke Sergott from Barclays set a target price of $310.0 on 04/27/2026
- Daniel Markowitz from Evercore ISI Group set a target price of $320.0 on 02/03/2026
- Kallum Titchmarsh from Morgan Stanley set a target price of $285.0 on 12/02/2025
Note that there may be inaccuracies in these estimates due to filing errors by the funds, parsing errors by us, or other anomalies.
Check out Quiver Quantitative's $WST ticker page for more data.
